Provided by Tiger Fintech (Singapore) Pte. Ltd.

NEWAMSTERDAM PHARMA CO NV

18.55
+0.72004.04%
Pre-market: 18.910.3600+1.94%04:09 EDT
Volume:424.05K
Turnover:7.75M
Market Cap:2.04B
PE:-7.24
High:18.62
Open:17.80
Low:17.43
Close:17.83
Loading ...

Press Release: NewAmsterdam Pharma Appoints Adele Gulfo to its Board of Directors

Dow Jones
·
18 Apr

NewAmsterdam Pharma Company (NAMS) Receives a Buy from TD Cowen

TIPRANKS
·
09 Apr

NewAmsterdam Pharma Price Target Maintained With a $42.00/Share by Needham

Dow Jones
·
08 Apr

Newamsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
05 Apr

Piper Sandler Sticks to Their Buy Rating for NewAmsterdam Pharma Company (NAMS)

TIPRANKS
·
01 Apr

William Blair Keeps Their Buy Rating on NewAmsterdam Pharma Company (NAMS)

TIPRANKS
·
01 Apr

NewAmsterdam Pharma to Present at the 24th Annual Needham Virtual Healthcare Conference

GlobeNewswire
·
31 Mar

NewAmsterdam Pharma Company Nv : Guggenheim Raises Target Price to $41 From $35

THOMSON REUTERS
·
03 Mar

NewAmsterdam Pharma files $500M mixed securities shelf

TIPRANKS
·
01 Mar

Analysts Offer Insights on Healthcare Companies: NewAmsterdam Pharma Company (NAMS) and Organogenesis Holdings (ORGO)

TIPRANKS
·
28 Feb

NewAmsterdam Pharma Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.
·
27 Feb

NewAmsterdam Pharma Is Maintained at Buy by Needham

Dow Jones
·
27 Feb

Newamsterdam Pharma Faces Potential Investor Risks Due to Shareholder Influence

TIPRANKS
·
27 Feb

NewAmsterdam Pharma Company (NAMS) Receives a Buy from William Blair

TIPRANKS
·
27 Feb

NewAmsterdam Pharma's Full-Year Net Loss Widens, Revenue Rises

MT Newswires Live
·
26 Feb

Earnings Flash (NAMS) NewAmsterdam Pharma Posts Full Year 2024 Revenue $45.6M, vs. FactSet Est of $33.8M

MT Newswires Live
·
26 Feb

Earnings Flash (NAMS) NewAmsterdam Pharma Posts Full Year 2024 Net Loss of $241.6M

MT Newswires Live
·
26 Feb

NewAmsterdam Pharma FY24 Sales $45.6M Beats $31.982M Estimate

Benzinga
·
26 Feb

Press Release: NewAmsterdam Pharma Reports Full Year 2024 Financial Results and Provides Corporate Update

Dow Jones
·
26 Feb

NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in March

GlobeNewswire
·
25 Feb